zolpidem has been researched along with Cerebral Infarction in 1 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To clarify the effects of zolpidem, a gamma-aminobutyric acid (GABA)(A) receptor agonist, on bladder function, and urine production, we investigated the effects of zolpidem administration on bladder overactivity induced by cerebral infarction (CI) and on urine excretion increased by water overloading in Wistar rats." | 3.76 | Zolpidem increases bladder capacity and decreases urine excretion in rats. ( Matsuta, Y; Ohtake, A; Sasamata, M; Suzuki, M; Watanabe, M; Yanai-Inamura, H; Yokoyama, O, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yokoyama, O | 1 |
| Matsuta, Y | 1 |
| Yanai-Inamura, H | 1 |
| Watanabe, M | 1 |
| Ohtake, A | 1 |
| Suzuki, M | 1 |
| Sasamata, M | 1 |
1 other study available for zolpidem and Cerebral Infarction
| Article | Year |
|---|---|
Zolpidem increases bladder capacity and decreases urine excretion in rats.
Topics: Aldosterone; Animals; Bicuculline; Cerebral Infarction; Disease Models, Animal; Dose-Response Relati | 2010 |